Showing results (41-50 of 47) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
BMC Medical Informatics and Decision Making|August 15, 2021
Patients-centered SurvivorShIp care plan after Cancer treatments based on Big Data and Artificial Intelligence technologies (PERSIST): a multicenter study protocol to evaluate efficacy of digital tools supporting cancer survivorsIzidor Mlakar, Simon Lin, Ilona Aleksandraviča, et al.International Journal of Molecular Sciences|January 28, 2026
Metal Pollution in the Air and Its Effects on Vulnerable Populations: A Narrative ReviewAdriana Gonzalez-Villalva, Marcela Rojas-Lemus, Nelly López-Valdez, et al.Primary Care Diabetes|May 25, 2023
Differences in weight loss and safety between the glucagon-like peptide-1 receptor agonists: A non-randomized multicenter study from the titration phaseJosé Seijas-Amigo, Ángel Salgado-Barreira, Rosana Castelo-Dominguez, et al.Journal of Cardiovascular Pharmacology|October 11, 2022
Patients With High Cardiovascular Risk as Candidates to Bempedoic Acid, After Treatment With Statins, Ezetimibe and PCSK9 Inhibitors: An Estimation and Cost-Effectiveness AnalysisJosé Seijas-Amigo, Alberto Cordero, Rosa F Olmo, et al.Journal of Clinical Apheresis|March 29, 2021
Incidence, diagnosis, and outcome of immune-mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpuraCristina Pascual-Izquierdo, Julio Del Rio-Garma, Javier de la Rubia, et al.Diabetes & Metabolic Syndrome|October 23, 2025
Effects of GLP-1 agonists on 10-year cardiovascular risk reduction in primary prevention: A 44-week open label prospective studyJosé Seijas-Amigo, Ángel Salgado-Barreira, Rosana Castelo-Dominguez, et al.Clinical Therapeutics|May 8, 2026
Real-world Impact of GLP-1 Receptor Agonists on Health-related Quality of Life in Type 2 Diabetes and Obesity (SEVERAL Study)José Seijas-Amigo, Ángel Salgado-Barreira, Carlota Roca-Martinez, et al.Pageof 5